Nichols & Pratt Advisers LLP Johnson & Johnson Transaction History

Nichols & Pratt Advisers LLP

$1.5 Billion
Q3 2024

A detailed history of Nichols & Pratt Advisers LLP transactions in Johnson & Johnson stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 504,770 shares of JNJ stock, worth $78.6 Million. This represents 5.45% of its overall portfolio holdings.

Number of Shares

504,770

Previous 506,467 0.34%

Holding current value

$78.6 Million

Previous $74 Million 10.51%

% of portfolio

5.45%

Previous 5.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$145.48 - $167.38 $246,879 - $284,043	-1,697 Reduced 0.34%	504,770 $81.8 Million
Q2 2024 Jul 25, 2024	SELL	$144.38 - $157.78 $71,756 - $78,416	-497 Reduced 0.1%	506,467 $74 Million
Q1 2024 Apr 29, 2024	SELL	$155.22 - $162.74 $653,631 - $685,298	-4,211 Reduced 0.82%	506,964 $80.2 Million
Q4 2023 Feb 07, 2024	SELL	$145.6 - $158.88 $1.47 Million - $1.61 Million	-10,120 Reduced 1.94%	511,175 $80.1 Million
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $662,249 - $741,888	-4,252 Reduced 0.81%	521,295 $81.2 Million
Q2 2023 Aug 02, 2023	SELL	$154.35 - $166.11 $472,002 - $507,964	-3,058 Reduced 0.58%	525,547 $87 Million
Q1 2023 May 03, 2023	BUY	$151.05 - $180.26 $181,260 - $216,312	1,200 Added 0.23%	528,605 $81.9 Million
Q4 2022 Feb 03, 2023	SELL	$160.2 - $179.79 $404,985 - $454,509	-2,528 Reduced 0.48%	527,405 $93.2 Million
Q3 2022 Nov 01, 2022	SELL	$161.33 - $179.52 $3.21 Million - $3.57 Million	-19,880 Reduced 3.62%	529,933 $86.6 Million
Q2 2022 Aug 04, 2022	SELL	$168.19 - $186.01 $996,862 - $1.1 Million	-5,927 Reduced 1.07%	549,813 $97.7 Million
Q1 2022 May 10, 2022	BUY	$158.14 - $179.59 $19,609 - $22,269	124 Added 0.02%	555,740 $98.5 Million
Q4 2021 Feb 08, 2022	SELL	$155.93 - $173.01 $314,043 - $348,442	-2,014 Reduced 0.36%	555,616 $95.1 Million
Q3 2021 Nov 01, 2021	SELL	$161.5 - $179.47 $860,956 - $956,754	-5,331 Reduced 0.95%	557,630 $89.4 Million
Q2 2021 Aug 09, 2021	SELL	$159.48 - $171.07 $2.5 Million - $2.69 Million	-15,700 Reduced 2.71%	562,961 $92.7 Million
Q1 2021 May 11, 2021	SELL	$153.07 - $170.48 $477,731 - $532,068	-3,121 Reduced 0.54%	578,661 $95 Million
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $470,013 - $539,498	-3,428 Reduced 0.59%	581,782 $91.5 Million
Q3 2020 Nov 10, 2020	SELL	$140.38 - $153.83 $2.39 Million - $2.62 Million	-17,011 Reduced 2.82%	585,210 $87.1 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $265,477 - $320,506	-2,061 Reduced 0.34%	602,221 $84.7 Million
Q1 2020 Apr 24, 2020	BUY	$111.14 - $153.99 $389,323 - $539,426	3,503 Added 0.58%	604,282 $79.2 Million
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $6.55 Million - $7.53 Million	-51,408 Reduced 7.88%	600,779 $87.6 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $1.3 Million - $1.45 Million	-10,231 Reduced 1.54%	652,187 $84.4 Million
Q2 2019 Aug 05, 2019	SELL	$131.15 - $144.24 $1 Million - $1.1 Million	-7,640 Reduced 1.14%	662,418 $92.3 Million
Q1 2019 Apr 30, 2019	SELL	$125.72 - $139.79 $3.84 Million - $4.27 Million	-30,526 Reduced 4.36%	670,058 $93.6 Million
Q4 2018 Feb 08, 2019	SELL	$122.84 - $147.84 $344,566 - $414,691	-2,805 Reduced 0.4%	700,584 $90.4 Million
Q3 2018 Nov 05, 2018	SELL	$121.58 - $142.88 $402,672 - $473,218	-3,312 Reduced 0.47%	703,389 $97.3 Million
Q2 2018 Jul 27, 2018	SELL	$119.4 - $131.76 $59,700 - $65,880	-500 Reduced 0.07%	706,701 $85.8 Million
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $389,936 - $461,752	-3,117 Reduced 0.44%	707,201 $90.5 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $102,876 - $112,598	-784 Reduced 0.11%	710,318 $99.2 Million
Q3 2017 Nov 08, 2017	SELL	$129.47 - $135.38 $1.33 Million - $1.39 Million	-10,258 Reduced 1.42%	711,102 $92.5 Million
Q2 2017 Aug 08, 2017	BUY	N/A	721,360	721,360 $95.5 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.

Account

Nichols & Pratt Advisers LLP Johnson & Johnson Transaction History